Cambodia vs Ireland: Previously treated cases tested for RR-/MDR-TB
Cambodia
72.0%
in 2024
Ireland
71.0%
in 2024
Cambodia rank
128th
Ireland rank
130th
Previously treated cases tested for RR-/MDR-TB over time
- Cambodia
- Ireland
How they compare
Cambodia currently reports 72.0% against 71.0% in Ireland, a difference of 1.0%.
The two have swapped places 5 times across 12 shared years of data; in 2007 it was Ireland ahead.
Cambodia ranks 128th and Ireland ranks 130th of 180 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.0% | 24.5% | 19.6% | Ireland |
| 2010s | 45.6% | 61.6% | 16.0% | Ireland |
| 2020s | 70.5% | 78.5% | 8.0% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cambodia or Ireland?
- Cambodia, at 72.0% against 71.0% in Ireland as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cambodia and Ireland?
- 1.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Ireland?
- 12 years are reported by both, from 2007 to 2024.
- How do Cambodia and Ireland rank globally for previously treated cases tested for rr-/mdr-tb?
- Cambodia ranks 128th and Ireland ranks 130th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.